Opti3D : Ready-to-use kits of artificial tumors® (96 to 384-well microplate) developed from agressive cancer types

OptiPASS : Synthetic culture media adapted to each cancer type

Patent LightSpot : Fluorescent probes to quantify cell resistance following treatment in microtissues or artificial tumors

For all the products, we propose a complete technical and human support in your facilities (Europe)